Femme et Homme
- | Pays :
- Bangladesh
- | Organes : -
- | Spécialités : -
Extrait
The main objective of this study is to provide immunogenicity data for GSK Biologicals' HRV vaccine when co-administered with OPV or when given alone (HRV vaccine dose given 15 days after the OPV dose).
Critère d'inclusion
- Infections, Rotavirus